134 related articles for article (PubMed ID: 8796324)
1. Crystallographic investigations of subtilisin BPN' mutants engineered for studying thermal stability.
Oliver JD; Rydel TJ; Strickland LC
Adv Exp Med Biol; 1996; 379():191-201. PubMed ID: 8796324
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
[TBL] [Abstract][Full Text] [Related]
3. Effects of engineered salt bridges on the stability of subtilisin BPN'.
Erwin CR; Barnett BL; Oliver JD; Sullivan JF
Protein Eng; 1990 Oct; 4(1):87-97. PubMed ID: 2127106
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure analysis of subtilisin BPN' mutants engineered for studying thermal stability.
Gilliland GL; Gallagher DT; Alexander P; Bryan P
Adv Exp Med Biol; 1996; 379():159-69. PubMed ID: 8796321
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
Braxton S; Wells JA
Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
[TBL] [Abstract][Full Text] [Related]
6. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
Neidhart DJ; Petsko GA
Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of thermitase at 1.4 A resolution.
Teplyakov AV; Kuranova IP; Harutyunyan EH; Vainshtein BK; Frömmel C; Höhne WE; Wilson KS
J Mol Biol; 1990 Jul; 214(1):261-79. PubMed ID: 2196375
[TBL] [Abstract][Full Text] [Related]
8. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
Bode W; Papamokos E; Musil D
Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of thermostability. Analysis of stabilizing mutations in subtilisin BPN'.
Almog O; Gallagher DT; Ladner JE; Strausberg S; Alexander P; Bryan P; Gilliland GL
J Biol Chem; 2002 Jul; 277(30):27553-8. PubMed ID: 12011071
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor).
Takeuchi Y; Noguchi S; Satow Y; Kojima S; Kumagai I; Miura K; Nakamura KT; Mitsui Y
Protein Eng; 1991 Jun; 4(5):501-8. PubMed ID: 1891457
[TBL] [Abstract][Full Text] [Related]
11. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the alkaline proteinase Savinase from Bacillus lentus at 1.4 A resolution.
Betzel C; Klupsch S; Papendorf G; Hastrup S; Branner S; Wilson KS
J Mol Biol; 1992 Jan; 223(2):427-45. PubMed ID: 1738156
[TBL] [Abstract][Full Text] [Related]
13. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
[TBL] [Abstract][Full Text] [Related]
14. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
[TBL] [Abstract][Full Text] [Related]
15. Engineering thermostability in subtilisin BPN' by in vitro mutagenesis.
Rollence ML; Filpula D; Pantoliano MW; Bryan PN
Crit Rev Biotechnol; 1988; 8(3):217-24. PubMed ID: 3145814
[TBL] [Abstract][Full Text] [Related]
16. The complete amino acid substitutions at position 131 that are positively involved in cold adaptation of subtilisin BPN'.
Taguchi S; Komada S; Momose H
Appl Environ Microbiol; 2000 Apr; 66(4):1410-5. PubMed ID: 10742220
[TBL] [Abstract][Full Text] [Related]
17. Subtilisin BPN' variants: increased hydrolytic activity on surface-bound substrates via decreased surface activity.
Brode PF; Erwin CR; Rauch DS; Barnett BL; Armpriester JM; Wang ES; Rubingh DN
Biochemistry; 1996 Mar; 35(10):3162-9. PubMed ID: 8605150
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
[TBL] [Abstract][Full Text] [Related]
19. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
Longstaff C; Campbell AF; Fersht AR
Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
[TBL] [Abstract][Full Text] [Related]
20. Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding.
Pantoliano MW; Whitlow M; Wood JF; Dodd SW; Hardman KD; Rollence ML; Bryan PN
Biochemistry; 1989 Sep; 28(18):7205-13. PubMed ID: 2684274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
